{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T13:00:26Z","timestamp":1772283626198,"version":"3.50.1"},"reference-count":10,"publisher":"IMR Press","issue":"2","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Neurol."],"DOI":"10.31083\/rn38994","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T12:11:13Z","timestamp":1772280673000},"source":"Crossref","is-referenced-by-count":0,"title":["Continuous Subcutaneous Apomorphine Infusion Therapy: Economic Impact in Spain"],"prefix":"10.31083","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0568-8231","authenticated-orcid":true,"given":"Lina","family":"Micolta-C\u00f3rdoba","sequence":"first","affiliation":[{"name":"Residente Geriatr\u00eda, Facultad de la Salud, Universidad del Valle, 760043 Santiago de Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7253-6304","authenticated-orcid":true,"given":"Juan Pablo","family":"Castro-Ramirez","sequence":"additional","affiliation":[{"name":"Departamento de Cl\u00ednicas M\u00e9dicas, Facultad de Ciencias de la Salud, Pontificia Universidad Javeriana, 720001 Cali, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7983-7791","authenticated-orcid":true,"given":"Carlos","family":"Reyes-Ortiz","sequence":"additional","affiliation":[{"name":"Institute of Public Health, College of Pharmacy and Pharmaceutical Sciences, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Afentou N, Jarl J, Gerdtham UG, Saha S. Economic Evaluation of Interventions in Parkinson\u2019s Disease: A Systematic Literature Review. Movement Disorders Clinical Practice. 2019; 6: 282\u2013290.","DOI":"10.1002\/mdc3.12755"},{"key":"ref2","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2021 (GBD 2021) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2022. Disponible en: https:\/\/vizhub.healthdata.org\/gbd-results\/ (Accedido: 23 Febrero 2025)."},{"key":"ref3","unstructured":"Cuenca MCS, Paz EC. Envejecimiento y dependencia en Espa\u00f1a: Un enfoque de pol\u00edticas p\u00fablicas. Revista Central de Sociolog\u00eda. 2024; 18: 8\u201331."},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Schr\u00f6ter N, Sajonz BEA, Jost WH, Rijntjes M, Coenen VA, Groppa S. Advanced therapies in Parkinson\u2019s disease: an individualized approach to their indication. Journal of Neural Transmission. 2024; 131: 1285\u20131293.","DOI":"10.1007\/s00702-024-02773-3"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Constantin VA, Sz\u00e1sz JA, Dulamea AO, Valkovic P, Kulisevsky J. Impact of Infusion Therapies on Quality of Life in Advanced Parkinson\u2019s Disease. Neuropsychiatric Disease and Treatment. 2023; 19: 1959\u20131972.","DOI":"10.2147\/NDT.S422717"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Fern\u00e1ndez C, Vargas-Mendoza AK, L\u00f3pez-L\u00f3pez B, Bl\u00e1zquez-Estrada M, Su\u00e1rez-San Mart\u00edn ME. Nocturnal continuous subcutaneous infusion of apomorphine in advanced Parkinson\u2019s disease: a series of 37 cases. Revista De Neurologia. 2024; 79: 217\u2013221.","DOI":"10.33588\/rn.7908.2024117"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Kukkle PL, Garg D, Merello M. Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson\u2019s Disease: A Systematic Review. Movement Disorders Clinical Practice. 2023; 10: 1253\u20131267.","DOI":"10.1002\/mdc3.13810"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Vivancos-Matellano F, Garcia-Ruiz AJ, Garcia-Agua Soler N. Pharmacoeconomic study of the treatment of advanced Parkinson\u2019s disease. Revista De Neurologia. 2016; 63: 529\u2013536.","DOI":"10.33588\/rn.6312.2016160"},{"key":"ref9","unstructured":"Instituto Nacional de Estad\u00edstica (INE). \u00cdndice de Precios de Consumo Base 2021: Sanidad. Madrid: INE; 2024. Disponible en: https:\/\/www.ine.es\/consul\/ (Accedido: 28 Febrero 2025)."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Vallejo-Torres L. Estimating the Incremental Cost Per QALY Produced by the Spanish NHS: A Fixed-Effect Econometric Approach. PharmacoEconomics. 2025; 43: 109\u2013122.","DOI":"10.1007\/s40273-024-01441-4"}],"container-title":["Revista de Neurolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RN\/81\/2\/10.31083\/RN38994","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T12:11:15Z","timestamp":1772280675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RN\/81\/2\/10.31083\/RN38994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"alternative-id":["S0210-0010(25)00046-5"],"URL":"https:\/\/doi.org\/10.31083\/rn38994","relation":{},"ISSN":["0210-0010","1576-6578"],"issn-type":[{"value":"0210-0010","type":"print"},{"value":"1576-6578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"article-number":"38994"}}